Skip to main content
Toggle navigation
Login
Search
Home
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Home
Browse by Poster Presenter
Browse by Poster Presenter
Type here to filter the list
All
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
K
Kaar, Joel
University of Colorado Boulder
(
W1330-01-01
)
Stabilization of Viruses for Vaccines and Gene Therapy by Spray Drying and Lyophilization
Joel Kaar
Favorite
Kadavil, Hana
Qatar University
(
W1330-01-04
)
Prolonged Ocular Delivery of Sunitinib from Poly (diol-tricarballylate) Injectable Biodegradable Elastomeric Tiny Implant for Diabetic Retinopathy Treatment
Hana Kadavil
Favorite
Kamath, Amrita
Genentech, Inc.
(
T1130-02-07
)
Anti-CCR8 Mediated Depletion of Tumor-Infiltrating Regulatory T Cells: Preclinical PK/PD and Translational Strategy in Support of Clinical Development for Solid Tumor Indications
Amrita Kamath
Favorite
(
T1430-02-08
)
Leveraging Buprenorphine as a Tool Molecule to Develop a Novel PBPK Model Accounting for Intestinal Lymphatic Absorption
Amrita Kamath
Favorite
(
T1530-02-07
)
Integrated HypoSkin® Model and PBPK Modeling as a Bioavailability Predicting Tool for Subcutaneous Delivery of Protein Therapeutics
Amrita Kamath
Favorite
Kapoor, Yash
Merck & Co., Inc.
(
T1230-01-01
)
Parallel-Competitive Absorption Metabolism Model for Calculation of Subcutaneous Bioavailability of Monoclonal Antibodies
Yash Kapoor
Favorite
Kassir, Nastya
Genentech, Inc.
(
T1430-02-09
)
Bridging Bevacizumab PK from Adults to Pediatrics through PBPK Modeling
Nastya Kassir
Favorite
Kathenes, Alexandra
AstraZeneca
(
W1230-02-09
)
LC-MS FFPE Tissue Analysis Across Multiple Murine Tissues Supports Mouse Relevance for On-Target/Off-Tumor Toxicity Assessment for Anti-STEAP2 CAR-T Therapeutic Development
Alexandra Kathenes
Favorite
Katsura, Shinji
Taiho Pharmaceutical Co., Ltd.
(
T1230-02-06
)
Interlaboratory Study of Multi-Attribute Method (MAM) for Antibody Therapeutics – Overview
Shinji Katsura
Favorite
(
T1430-02-06
)
Interlaboratory Study of Multi-Attribute Method (MAM) for Antibody Therapeutics – Post-Translational Modification (1) C-terminal Lys Clipping
Shinji Katsura
Favorite
(
W1130-02-06
)
Interlaboratory Study of Multi-Attribute Method (MAM) for Antibody Therapeutics – Post-Translational Modification (2) Oxidation
Shinji Katsura
Favorite
(
W1330-02-06
)
Interlaboratory Study of Multi-Attribute Method (MAM) for Antibody Therapeutics – Post-Translational Modification (1) Deamidation
Shinji Katsura
Favorite
Kaur, Indu Pal
Panjab University
(
W1230-02-07
)
Docetaxel and QDs Based Nano Lipidic Theragnostic System for Cure and Real-Time Monitoring of Breast Cancer: Efficacy and Safety Studies in Rats
Indu Pal Kaur
Favorite
Kawakami, Kohsaku
National Institute for Materials Science
(
T1030-01-01
)
Development of Physicochemical Profiling Platform for Therapeutic Oligonucleotides
Kohsaku Kawakami
Favorite
(
T1230-02-06
)
Interlaboratory Study of Multi-Attribute Method (MAM) for Antibody Therapeutics – Overview
Kohsaku Kawakami
Favorite
(
T1330-01-01
)
Development of Physicochemical Profiling Platform for Therapeutic Oligonucleotides II Circular Dichroism Spectroscopy and Nuclear Magnetic Resonance Analysis for Determining Higher-Order Structure
Kohsaku Kawakami
Favorite
(
T1430-02-06
)
Interlaboratory Study of Multi-Attribute Method (MAM) for Antibody Therapeutics – Post-Translational Modification (1) C-terminal Lys Clipping
Kohsaku Kawakami
Favorite
(
W1030-01-01
)
Development of Physicochemical Profiling Platform for Therapeutic Oligonucleotides III Thermodynamic Analysis on Higher-Order Structure of Oligonucleotides
Kohsaku Kawakami
Favorite
(
W1130-02-06
)
Interlaboratory Study of Multi-Attribute Method (MAM) for Antibody Therapeutics – Post-Translational Modification (2) Oxidation
Kohsaku Kawakami
Favorite
(
W1230-01-01
)
Development of Physicochemical Profiling Platform for Therapeutic Oligonucleotides IV Evaluation of Compactness of Oligonucleotides for Determining Their Higher-Order Structure
Kohsaku Kawakami
Favorite
(
W1330-02-06
)
Interlaboratory Study of Multi-Attribute Method (MAM) for Antibody Therapeutics – Post-Translational Modification (1) Deamidation
Kohsaku Kawakami
Favorite
(
W1430-01-01
)
Development of Physicochemical Profiling Platform for Therapeutic Oligonucleotides V Biological Function Analysis of Oligodeoxynucleotides
Kohsaku Kawakami
Favorite
Kawase, Naoki
Astellas Pharm Inc.
(
T1230-02-06
)
Interlaboratory Study of Multi-Attribute Method (MAM) for Antibody Therapeutics – Overview
Naoki Kawase
Favorite
(
T1430-02-06
)
Interlaboratory Study of Multi-Attribute Method (MAM) for Antibody Therapeutics – Post-Translational Modification (1) C-terminal Lys Clipping
Naoki Kawase
Favorite
(
W1130-02-06
)
Interlaboratory Study of Multi-Attribute Method (MAM) for Antibody Therapeutics – Post-Translational Modification (2) Oxidation
Naoki Kawase
Favorite
(
W1330-02-06
)
Interlaboratory Study of Multi-Attribute Method (MAM) for Antibody Therapeutics – Post-Translational Modification (1) Deamidation
Naoki Kawase
Favorite
Kayoka, Kamba
Moderna Therapeutics
(
T1530-02-06
)
Development of an Electrochemiluminescent Assay for the Detection of Anti-PEG IgE Antibodies in Human Serum
Kamba Kayoka
Favorite
Kazeroonian, Atefeh
Differentia Bio
(
T1030-02-06
)
A Mechanistic Model of IgG4-RD Identifies High-Potential Therapy Targets
Atefeh Kazeroonian
Favorite
Kelly, Adrian
University of Bradford
(
T1030-02-08
)
Single Cell Gel Electrophoresis to Detect Genotoxicity of Iminostilbene, a Process Induced Impurity of Carbamazepine
Adrian Kelly
Favorite
Kendle, Wesley
BioAgilytix Labs
(
W1530-02-09
)
Development of Non-Cell Based Potency Assays for Bispecific Antibodies
Wesley Kendle
Favorite
Kennedy, Derek
Ultragenyx Pharmaceuticals
(
W1530-02-06
)
Age-Dependent Reduction in Hepatic Vector Genome Loss in Juvenile OTC
spf-ash
Mice Following a Single Dose of DTX301 and Partial Compensation Achieved with a Higher Dose
Derek Kennedy
Favorite
Keve, Steve
Ultragenyx Pharmaceuticals
(
W1430-02-10
)
Analysis of Anti-Drug Antibodies (ADA) in Multiple Animal Species from mRNA LNP Therapeutics Supporting Rare Diseases Demonstrated Low Immunogenicity of PEG-2000 by ECLA and ELISA Methodology
Steve Keve
Favorite
Keyhani, Anahita
Altasciences
(
T1230-02-11
)
Sensitive Quantitation of Antisense Oligonucleotides Using Capitainer
®
qDBS Microsampling Device Coupled with Hybridization LC-MS/MS
Anahita Keyhani
Favorite
Khanna, Pooja
Merck & Co., Inc.
(
W1330-02-07
)
Enhancing Antibody Detection for PABAD-Based Neutralizing Antibody Detection and Validation
Pooja Khanna
Favorite
Khosraviani, Mehraban
Genentech, Inc.
(
T1330-02-08
)
Production and Characterization of Critical Biotin and DIG Conjugated RESCA-Anti-CD8 VHH Reagents to Enable the Non-Clinical and Clinical Anti-Drug Antibody Assay Development
Mehraban Khosraviani
Favorite
Kiang, Patty
Cellentia, Inc.
(
T1330-02-10
)
Novel Immunoassay Technology: Evaluating the PIXI Platform for Rapid Quantitation with Automation, Wide Dynamic Range, and Small Sample Volume Requirement
Patty Kiang
Favorite
Kim, Hyun-Jung
AstraZeneca
(
T1130-02-06
)
Biodistribution Analysis of GPC-3 CAR-T Cells in NSG Mice by a Universal ddPCR Assay to Support an IND-Enabling Toxicity Study
Hyun-Jung Kim
Favorite
Kim, Inyong
Mayo Clinic
(
W1430-01-04
)
Innovative Device for Concomitant Therapeutic Compound Delivery into the Brain and Neural Recordings - Feasibility Bench and In Vivo Studies
Inyong Kim
Favorite
Kim, Jiwon
Mayo Clinic
(
W1430-01-04
)
Innovative Device for Concomitant Therapeutic Compound Delivery into the Brain and Neural Recordings - Feasibility Bench and In Vivo Studies
Jiwon Kim
Favorite
Kim, Michael
Genentech, Inc.
(
T1430-01-03
)
Val-His-Ser (VHS) N-terminal Leader Sequence and Implications for mAb Subcutaneous Pharmacokinetics
Michael Kim
Favorite
Kim, Sang Yeop
Merck & Co., Inc.
(
T1230-02-08
)
Quantitation of Soluble Tumor-Associated Antigens (sTAA) in Tumor Interstitial Fluid (TIF) Isolated from Frozen Solid Tumors
Sang Yeop Kim
Favorite
Kim, Sunjung
Ultragenyx Pharmaceuticals
(
W1530-02-06
)
Age-Dependent Reduction in Hepatic Vector Genome Loss in Juvenile OTC
spf-ash
Mice Following a Single Dose of DTX301 and Partial Compensation Achieved with a Higher Dose
Sunjung Kim
Favorite
Kinne, Adam
B2S Life Sciences
(
W1430-02-06
)
Application of a Novel Affinity Purified Chicken IgY in an Immunoaffinity LC-MS/MS Assay for Rapid Quantitation of Monoclonal Antibody Therapeutics and ADCs in Nonclinical Species
Adam Kinne
Favorite
Klauss, Linda
Gyros Protein Technologies
(
T1530-02-10
)
Development of a Generic, Automated, Microfluidic Human IgG-FcRn Affinity Assay In-Solution for Use in Antibody Engineering
Linda Klauss
Favorite
Koerber, James
Genentech, Inc.
(
T1130-02-07
)
Anti-CCR8 Mediated Depletion of Tumor-Infiltrating Regulatory T Cells: Preclinical PK/PD and Translational Strategy in Support of Clinical Development for Solid Tumor Indications
James Koerber
Favorite
Kogaki, Takahiro
Daiichi Sankyo Co., Ltd.
(
T1230-02-06
)
Interlaboratory Study of Multi-Attribute Method (MAM) for Antibody Therapeutics – Overview
Takahiro Kogaki
Favorite
(
T1430-02-06
)
Interlaboratory Study of Multi-Attribute Method (MAM) for Antibody Therapeutics – Post-Translational Modification (1) C-terminal Lys Clipping
Takahiro Kogaki
Favorite
(
W1130-02-06
)
Interlaboratory Study of Multi-Attribute Method (MAM) for Antibody Therapeutics – Post-Translational Modification (2) Oxidation
Takahiro Kogaki
Favorite
(
W1330-02-06
)
Interlaboratory Study of Multi-Attribute Method (MAM) for Antibody Therapeutics – Post-Translational Modification (1) Deamidation
Takahiro Kogaki
Favorite
Kommineni, Nagavendra
Rockefeller University
(
W1330-01-02
)
Poloxamer 188 and Propylene Glycol Loaded with Novel Pyridine-Based 1,2,4-Triazolo-Tethered Indole Conjugate as Rectal Suppository to Treat Colorectal Cancer
Nagavendra Kommineni
Favorite
Komura, Fusae
Eisai Co., Ltd.
(
T1030-01-01
)
Development of Physicochemical Profiling Platform for Therapeutic Oligonucleotides
Fusae Komura
Favorite
(
T1330-01-01
)
Development of Physicochemical Profiling Platform for Therapeutic Oligonucleotides II Circular Dichroism Spectroscopy and Nuclear Magnetic Resonance Analysis for Determining Higher-Order Structure
Fusae Komura
Favorite
Korde, Sachin A
University of Bradford
(
T1030-02-08
)
Single Cell Gel Electrophoresis to Detect Genotoxicity of Iminostilbene, a Process Induced Impurity of Carbamazepine
Sachin A Korde
Favorite
Koscec, Mirna
Ultragenyx Pharmaceuticals
(
W1430-02-10
)
Analysis of Anti-Drug Antibodies (ADA) in Multiple Animal Species from mRNA LNP Therapeutics Supporting Rare Diseases Demonstrated Low Immunogenicity of PEG-2000 by ECLA and ELISA Methodology
Mirna Koscec
Favorite
Kullmann, Aura
NeuroOne
(
W1430-01-04
)
Innovative Device for Concomitant Therapeutic Compound Delivery into the Brain and Neural Recordings - Feasibility Bench and In Vivo Studies
Aura Kullmann
Favorite
Kumar, Rajender
Post Graduate Institute of Medical Education and Research
(
W1530-02-08
)
Non-invasive Molecular Imaging of V3 Receptors to Localize ACTH-Dependent Cushing's Syndrome and Precision Surgery of Corticotropinoma
Rajender Kumar
Favorite
